Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
serpin family H member 1 | 0.545 | 0.769 | 2.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 8 | 4 | 2010 | 2019 | ||||||||
|
quiescin sulfhydryl oxidase 2 | 0.890 | 0.077 | 9.8E-08 |
|
phenotype | 0.100 | None | 1.000 | 7 | 7 | 2010 | 2019 | ||||||||
|
JAZF zinc finger 1 | 0.582 | 0.654 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 7 | 9 | 2009 | 2019 | ||||||||
|
lin-28 homolog B | 0.556 | 0.654 | 0.56 |
|
phenotype | 0.100 | None | 1.000 | 7 | 6 | 2008 | 2019 | ||||||||
|
mitogen-activated protein kinase kinase kinase 3 | 0.626 | 0.692 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 7 | 5 | 2008 | 2019 | ||||||||
|
growth differentiation factor 5 | 0.511 | 0.692 | 0.67 |
|
phenotype | 0.100 | None | 1.000 | 7 | 3 | 2010 | 2019 | ||||||||
|
synapsin III | 0.686 | 0.462 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 7 | 6 | 2010 | 2019 | ||||||||
|
far upstream element binding protein 3 | 1.000 | 0.077 | 0.80 |
|
phenotype | 0.100 | None | 1.000 | 7 | 3 | 2008 | 2019 | ||||||||
|
MEF2C antisense RNA 1 | 0.861 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2010 | 2019 | |||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 10 | 2010 | 2019 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 6 | 4 | 2010 | 2019 | ||||||||
|
growth hormone secretagogue receptor | 0.528 | 0.769 | 6.6E-03 |
|
phenotype | 0.100 | None | 1.000 | 6 | 3 | 2010 | 2019 | ||||||||
|
zinc finger protein 638 | 0.931 | 0.154 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2013 | 2019 | ||||||||
|
chromosome 14 open reading frame 39 | 0.861 | 0.038 | 2.7E-06 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2010 | 2019 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2010 | 2019 | ||||||||
|
latent transforming growth factor beta binding protein 2 | 0.572 | 0.692 | 7.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 6 | 4 | 2010 | 2019 | ||||||||
|
microfibril associated protein 2 | 0.769 | 0.423 | 4.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2010 | 2019 | ||||||||
|
natriuretic peptide receptor 3 | 0.633 | 0.615 | 1.0E-05 |
|
phenotype | 0.100 | None | 1.000 | 6 | 7 | 2010 | 2019 | ||||||||
|
proprotein convertase subtilisin/kexin type 5 | 0.659 | 0.538 | 2.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 6 | 6 | 2010 | 2019 | ||||||||
|
zinc finger MIZ-type containing 1 | 0.588 | 0.615 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2010 | 2019 | ||||||||
|
slit guidance ligand 3 | 0.623 | 0.615 | 0.75 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2010 | 2019 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 5 | 2010 | 2019 | ||||||||
|
disrupted in renal carcinoma 3 | 0.780 | 0.308 | 3.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 6 | 7 | 2010 | 2019 | ||||||||
|
DOT1 like histone lysine methyltransferase | 0.599 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 6 | 4 | 2008 | 2019 | ||||||||
|
CASP2 and RIPK1 domain containing adaptor with death domain | 0.619 | 0.500 | 0.88 |
|
phenotype | 0.100 | None | 1.000 | 6 | 8 | 2010 | 2019 |